The agency has warned about dosing errors, fraudulent labels, improper shipping temperatures and questionable online sources
Dysfunction in GLP-1R signaling has been implicated in multiple pathologies, including type 2 diabetes mellitus (T2DM), obesity, atherosclerosis, Parkinsons disease (PD), Alzheimers disease (AD), non-alcoholic steatohepatitis (NASH), and several cancers
It is administered once daily by subcutaneous injection
74 The increased supply of glucose into these tissues results in the promotion of glycogen synthesis or increased fat storage under resting conditions
Doctors start their patients on lower starter doses and work their way up it can take months to work up to a full-strength dosage
Realistic expectations include 10-15% weight loss over 6-12 months, with individual variation